People over 50 years old or with existing kidney dysfunction are more likely to get kidney damage when using tenofovir disoproxil-based PrEP
One dose of TAF every three days gets more drug into cells than a daily dose of TDF
Ultra-short course treatment for hepatitis C: high failure rate but does not compromise second-line treatment
Dolutegravir more likely to suppress very high viral loads than other recommended first-line drugs
Adult healthcare providers need to build long-term trusting relationship with adolescents living with HIV
Large review finds some evidence that peer support is beneficial in HIV care
Menopausal women living with HIV need better information on how to manage symptoms
Treatment interruption in cure research is associated with greater risk of non-AIDS related events in the long term, Spanish study finds
Untreated HIV, low CD4 count or unsuppressed viral load raise the risk of COVID-19 death in South Africa
